Global Meningococcal Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Meningococcal Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
According to APO Research, The global Meningococcal Vaccine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Meningococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Meningococcal Vaccine include Novartis, GSK, Merck, CSL, Baxter, JN International Medical Corporation, Serum Institute of India, Bio-Med and China National Biotec Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningococcal Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningococcal Vaccine.
The Meningococcal Vaccine market size, estimations, and forecasts are provided in terms of sales volume (10K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meningococcal Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Meningococcal Vaccine segment by Type

Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Meningococcal Vaccine segment by Application

6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Meningococcal Vaccine Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meningococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meningococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meningococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Meningococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Meningococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Meningococcal Vaccine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Meningococcal Vaccine Sales Estimates and Forecasts (2019-2030)
1.3 Meningococcal Vaccine Market by Type
1.3.1 Meningtits A
1.3.2 Polysaccharide Meningtitis AC
1.3.3 Meningitis ACYW
1.4 Global Meningococcal Vaccine Market Size by Type
1.4.1 Global Meningococcal Vaccine Market Size Overview by Type (2019-2030)
1.4.2 Global Meningococcal Vaccine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Meningococcal Vaccine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Meningococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Meningococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Meningococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Meningococcal Vaccine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Meningococcal Vaccine Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Meningococcal Vaccine Industry Trends
2.2 Meningococcal Vaccine Industry Drivers
2.3 Meningococcal Vaccine Industry Opportunities and Challenges
2.4 Meningococcal Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Meningococcal Vaccine Revenue (2019-2024)
3.2 Global Top Players by Meningococcal Vaccine Sales (2019-2024)
3.3 Global Top Players by Meningococcal Vaccine Price (2019-2024)
3.4 Global Meningococcal Vaccine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Meningococcal Vaccine Key Company Manufacturing Sites & Headquarters
3.6 Global Meningococcal Vaccine Company, Product Type & Application
3.7 Global Meningococcal Vaccine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Meningococcal Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Meningococcal Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Meningococcal Vaccine Tier 1, Tier 2, and Tier 3
4 Meningococcal Vaccine Regional Status and Outlook
4.1 Global Meningococcal Vaccine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Meningococcal Vaccine Historic Market Size by Region
4.2.1 Global Meningococcal Vaccine Sales in Volume by Region (2019-2024)
4.2.2 Global Meningococcal Vaccine Sales in Value by Region (2019-2024)
4.2.3 Global Meningococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Meningococcal Vaccine Forecasted Market Size by Region
4.3.1 Global Meningococcal Vaccine Sales in Volume by Region (2025-2030)
4.3.2 Global Meningococcal Vaccine Sales in Value by Region (2025-2030)
4.3.3 Global Meningococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Meningococcal Vaccine by Application
5.1 Meningococcal Vaccine Market by Application
5.1.1 6 Months-15Year
5.1.2 over 3 Year
5.1.3 over 2 Year
5.1.4 over 3 Months
5.2 Global Meningococcal Vaccine Market Size by Application
5.2.1 Global Meningococcal Vaccine Market Size Overview by Application (2019-2030)
5.2.2 Global Meningococcal Vaccine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Meningococcal Vaccine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Meningococcal Vaccine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Meningococcal Vaccine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Meningococcal Vaccine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Meningococcal Vaccine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Meningococcal Vaccine Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Novartis
6.1.1 Novartis Comapny Information
6.1.2 Novartis Business Overview
6.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Meningococcal Vaccine Product Portfolio
6.1.5 Novartis Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Meningococcal Vaccine Product Portfolio
6.2.5 GSK Recent Developments
6.3 Merck
6.3.1 Merck Comapny Information
6.3.2 Merck Business Overview
6.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Meningococcal Vaccine Product Portfolio
6.3.5 Merck Recent Developments
6.4 CSL
6.4.1 CSL Comapny Information
6.4.2 CSL Business Overview
6.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Meningococcal Vaccine Product Portfolio
6.4.5 CSL Recent Developments
6.5 Baxter
6.5.1 Baxter Comapny Information
6.5.2 Baxter Business Overview
6.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Baxter Meningococcal Vaccine Product Portfolio
6.5.5 Baxter Recent Developments
6.6 JN International Medical Corporation
6.6.1 JN International Medical Corporation Comapny Information
6.6.2 JN International Medical Corporation Business Overview
6.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JN International Medical Corporation Meningococcal Vaccine Product Portfolio
6.6.5 JN International Medical Corporation Recent Developments
6.7 Serum Institute of India
6.7.1 Serum Institute of India Comapny Information
6.7.2 Serum Institute of India Business Overview
6.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Serum Institute of India Meningococcal Vaccine Product Portfolio
6.7.5 Serum Institute of India Recent Developments
6.8 Bio-Med
6.8.1 Bio-Med Comapny Information
6.8.2 Bio-Med Business Overview
6.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Med Meningococcal Vaccine Product Portfolio
6.8.5 Bio-Med Recent Developments
6.9 China National Biotec Group
6.9.1 China National Biotec Group Comapny Information
6.9.2 China National Biotec Group Business Overview
6.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 China National Biotec Group Meningococcal Vaccine Product Portfolio
6.9.5 China National Biotec Group Recent Developments
6.10 Hualan Bio
6.10.1 Hualan Bio Comapny Information
6.10.2 Hualan Bio Business Overview
6.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hualan Bio Meningococcal Vaccine Product Portfolio
6.10.5 Hualan Bio Recent Developments
6.11 Walvax
6.11.1 Walvax Comapny Information
6.11.2 Walvax Business Overview
6.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Walvax Meningococcal Vaccine Product Portfolio
6.11.5 Walvax Recent Developments
6.12 Zhifei
6.12.1 Zhifei Comapny Information
6.12.2 Zhifei Business Overview
6.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhifei Meningococcal Vaccine Product Portfolio
6.12.5 Zhifei Recent Developments
7 North America by Country
7.1 North America Meningococcal Vaccine Sales by Country
7.1.1 North America Meningococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Meningococcal Vaccine Sales by Country (2019-2024)
7.1.3 North America Meningococcal Vaccine Sales Forecast by Country (2025-2030)
7.2 North America Meningococcal Vaccine Market Size by Country
7.2.1 North America Meningococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Meningococcal Vaccine Market Size by Country (2019-2024)
7.2.3 North America Meningococcal Vaccine Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Meningococcal Vaccine Sales by Country
8.1.1 Europe Meningococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Meningococcal Vaccine Sales by Country (2019-2024)
8.1.3 Europe Meningococcal Vaccine Sales Forecast by Country (2025-2030)
8.2 Europe Meningococcal Vaccine Market Size by Country
8.2.1 Europe Meningococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Meningococcal Vaccine Market Size by Country (2019-2024)
8.2.3 Europe Meningococcal Vaccine Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Meningococcal Vaccine Sales by Country
9.1.1 Asia-Pacific Meningococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Meningococcal Vaccine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Meningococcal Vaccine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Meningococcal Vaccine Market Size by Country
9.2.1 Asia-Pacific Meningococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Meningococcal Vaccine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Meningococcal Vaccine Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Meningococcal Vaccine Sales by Country
10.1.1 Latin America Meningococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Meningococcal Vaccine Sales by Country (2019-2024)
10.1.3 Latin America Meningococcal Vaccine Sales Forecast by Country (2025-2030)
10.2 Latin America Meningococcal Vaccine Market Size by Country
10.2.1 Latin America Meningococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Meningococcal Vaccine Market Size by Country (2019-2024)
10.2.3 Latin America Meningococcal Vaccine Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Meningococcal Vaccine Sales by Country
11.1.1 Middle East and Africa Meningococcal Vaccine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Meningococcal Vaccine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Meningococcal Vaccine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Meningococcal Vaccine Market Size by Country
11.2.1 Middle East and Africa Meningococcal Vaccine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Meningococcal Vaccine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Meningococcal Vaccine Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Meningococcal Vaccine Value Chain Analysis
12.1.1 Meningococcal Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Meningococcal Vaccine Production Mode & Process
12.2 Meningococcal Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Meningococcal Vaccine Distributors
12.2.3 Meningococcal Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings